Jeffrey David Kerby

Jeffrey David Kerby

Auto-generated profile, based on publicly available information

Jeffrey David Kerby

Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2005 in Shock
Verified
Journal Article
Closed access
WHWilliam J Hubbard
William J Hubbard
MCMashkoor Choudhry
Mashkoor Choudhry
MSMartin G Schwacha
Martin G Schwacha
JKJeffrey D Kerby
Jeffrey D Kerby
LRLoring W Rue
Loring W Rue
ICIrshad H Chaudry
Irshad H Chaudry
The model of cecal ligation and puncture (CLP) in rodents has been used extensively to investigate the clinical settings of sepsis and septic shock. This model produces a hyperdynamic, hypermetabolic state that can lead to a hypodynamic, hypometabolic stage, and eventual death. Blood cultures are positive for enteric organisms very early after CLP. The model has been widely used over the past 26 years and is highly versatile in adapting to a range of severity and testing objectives. It is inexpensive to prepare and technically straightforward. Aspects of sepsis research investigated using CLP include energetics, metabolism, resuscitation, antibiotic therapy, microbial factors, cardiovascular responses, immune function, mediator release, and cytokine expression patterns. The challenge of the small circulating blood volume in rodents can be overcome by using micromethods that enable analysis of small volumes, or alternatively, by using a large number of animals to obtain serial samples.

1 April 2015 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
MSMartin A. Schreiber
Martin A. Schreiber
EMEric N. Meier
Eric N. Meier
STSamuel A. Tisherman
Samuel A. Tisherman
JKJeffrey D. Kerby
Jeffrey D. Kerby
CNCraig D. Newgard
Craig D. Newgard
DHDavid B. Hoyt
David B. Hoyt
BACKGROUND Optimal resuscitation of hypotensive trauma patients has not been defined. This trial was performed to assess the feasibility and safety of controlled resuscitation (CR) versus standard resuscitation (SR) in hypotensive trauma patients. METHODS Patients were enrolled and randomized in the out-of-hospital setting. Nineteen emergency medical services (EMS) systems in the Resuscitation Outcome Consortium participated. Eligible patients had an out-of-hospital systolic blood pressure (SBP) of 90 mm Hg or lower. CR patients received 250 mL of fluid if they had no radial pulse or an SBP lower than 70 mm Hg and additional 250-mL boluses to maintain a radial pulse or an SBP of 70 mm Hg or greater. The SR group patients received 2 L initially and additional fluid as needed to maintain an SBP of 110 mm Hg or greater. The crystalloid protocol was maintained until hemorrhage control or 2 hours after hospital arrival. RESULTS A total of 192 patients were randomized (97 CR and 95 SR). The CR and SR groups were similar at baseline. The mean (SD) crystalloid volume administered during the study period was 1.0 L (1.5) in the CR group and 2.0 L (1.4) in the SR group, a difference of 1.0 L (95% confidence interval [CI], 0.6–1.4). Intensive care unit–free days, ventilator-free days, renal injury, and renal failure did not differ between the groups. At 24 hours after admission, there were 5 deaths (5%) in the CR group and 14 (15%) in the SR group (adjusted odds ratio, 0.39; 95% CI, 0.12–1.26). Among patients with blunt trauma, 24-hour mortality was 3% (CR) and 18% (SR) with an adjusted odds ratio of 0.17 (0.03–0.92). There was no difference among patients with penetrating trauma (9% vs. 9%; adjusted odds ratio, 1.93; 95% CI, 0.19–19.17). CONCLUSION CR is achievable in out-of-hospital and hospital settings and may offer an early survival advantage in blunt trauma. A large-scale, Phase III trial to examine its effects on survival and other clinical outcomes is warranted. LEVEL OF EVIDENCE Therapeutic study, level I.

1 September 2012 in Annals of Surgery
Verified
Journal Article
Closed access
JKJeffrey D. Kerby
Jeffrey D. Kerby
RGRussell L. Griffin
Russell L. Griffin
PMPaul MacLennan
Paul MacLennan
LRLoring W. Iii Rue
Loring W. Iii Rue
Objectives: To identify all trauma patients with diabetes and compare diabetic hyperglycemia (DH) patients with those with stress-induced hyperglycemia (SIH). Background: SIH has been shown to result in worse outcomes after trauma. The presence of diabetes mellitus (DM) or occult DM within the cohort confounded previous studies. We identified 2 distinct populations of trauma patients with SIH or DH to determine the impact of hyperglycemia on these 2 groups. Methods: Admission glycosylated hemoglobin (HbA1c), glucose levels, and comorbidity data were collected over a 2-year period. DM was determined by patient history or admission HbA1c 6.5% or more. SIH was determined by absence of DM and admission glucose 200 mg/dL or more. Cox proportional hazards models [adjusted for age, sex, injury mechanism, and injury severity score] were used to calculate risk ratios (RRs) and associated 95% confidence intervals (CIs) for outcomes of interest. Results: During the study period, 6852 trauma patients were evaluated, and 5117 had available glucose, HbA1c, and comorbidity data. Patients with SIH had an over twofold increase in mortality risk (RR 2.41, 95% CI 1.81–3.23), and patients with DH had a nonsignificant, near-50% increase in mortality risk (RR 1.47, 95% CI 0.92–2.36). Risk of pneumonia was similarly higher for both the DH (RR 1.49, 95% CI 1.03–2.17) and the SIH (RR 1.44, 95% CI 1.08–1.93). Conclusions: DM is common in patients with hyperglycemia after trauma. As opposed to DH, SIH is associated with higher mortality after trauma. Further research is warranted to identify mechanisms causing hyperglycemia and subsequent worse outcomes after trauma.

1 December 2005 in Shock
Verified
Journal Article
Closed access
MCMashkoor A Choudhry
Mashkoor A Choudhry
MSMartin G Schwacha
Martin G Schwacha
WHWilliam J Hubbard
William J Hubbard
JKJeffrey D Kerby
Jeffrey D Kerby
LRLoring W Rue
Loring W Rue
ICIrshad H Chaudry
Irshad H Chaudry
To understand the pathogenesis of a disease, experimental models are needed. A good experimental model is the one that simulates responses observed in the clinical setting. In recent years, clinical studies have indicated that gender might be a factor that plays a significant role in the outcome of patients with shock, trauma, and sepsis. These observations are now being evaluated in experimental setting. Studies performed in a rodent model of trauma-hemorrhage have concluded that alterations in immune and cardiac functions after trauma-hemorrhage are more markedly depressed in adult males, and ovariectomized and aged females. However, both are maintained in castrated males and in proestrus females. Moreover, the survival rate of proestrus females subjected to sepsis after trauma-hemorrhage is significantly higher than age-matched males or ovariectomized females. Although these observations suggest gender-specific response after trauma-hemorrhage, the mechanisms responsible for gender specificity remain largely unknown. Furthermore, in other injuries such as burn, experimental studies dealing with sexual dimorphism are limited. Therefore, more studies in clinical and experimental settings are required to determine whether gender-specific responses are global across the injuries or are observed in specific injury situations. Studies are also needed to delineate underlying mechanisms responsible for differences between males and females after trauma-hemorrhage. The information gained from the experimental studies will help in designing innovative therapeutic approaches for the treatment of trauma patients.

1 June 2014 in Shock
Verified
Journal Article
Closed access
SCSarah C. Christiaans
Sarah C. Christiaans
ADAmy L. Duhachek-Stapelman
Amy L. Duhachek-Stapelman
RRRobert T. Russell
Robert T. Russell
SLSteven J. Lisco
Steven J. Lisco
JKJeffrey D. Kerby
Jeffrey D. Kerby
JPJean-François Pittet
Jean-François Pittet
Trauma remains the leading cause of morbidity and mortality in the United States among children aged 1 to 21 years. The most common cause of lethality in pediatric trauma is traumatic brain injury. Early coagulopathy has been commonly observed after severe trauma and is usually associated with severe hemorrhage and/or traumatic brain injury. In contrast to adult patients, massive bleeding is less common after pediatric trauma. The classical drivers of trauma-induced coagulopathy include hypothermia, acidosis, hemodilution, and consumption of coagulation factors secondary to local activation of the coagulation system after severe traumatic injury. Furthermore, there is also recent evidence for a distinct mechanism of trauma-induced coagulopathy that involves the activation of the anticoagulant protein C pathway. Whether this new mechanism of posttraumatic coagulopathy plays a role in children is still unknown. The goal of this review is to summarize the current knowledge on the incidence and potential mechanisms of coagulopathy after pediatric trauma and the role of rapid diagnostic tests for early identification of coagulopathy. Finally, we discuss different options for treating coagulopathy after severe pediatric trauma.

19 March 2019 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
RCRonald Chang
Ronald Chang
JKJeffrey D. Kerby
Jeffrey D. Kerby
KKKyle J. Kalkwarf
Kyle J. Kalkwarf
GBGerald Van Belle
Gerald Van Belle
EFErin E. Fox
Erin E. Fox
PGPROPPR Study Group
PROPPR Study Group
BACKDROP: Clinicians intuitively recognize that faster time to hemostasis is important in bleeding trauma patients, but these times are rarely reported. METHODS: Prospectively collected data from the Pragmatic Randomized Optimal Platelet and Plasma Ratios trial were analyzed. Hemostasis was predefined as no intraoperative bleeding requiring intervention in the surgical field or resolution of contrast blush on interventional radiology (IR). Patients who underwent an emergent (within 90 minutes) operating room (OR) or IR procedure were included. Mixed-effects Poisson regression with robust error variance (controlling for age, Injury Severity Score, treatment arm, injury mechanism, base excess on admission [missing values estimated by multiple imputation], and time to OR/IR as fixed effects and study site as a random effect) with modified Bonferroni corrections tested the hypothesis that decreased time to hemostasis was associated with decreased mortality and decreased incidence of acute kidney injury (AKI), acute respiratory distress syndrome (ARDS), multiple-organ failure (MOF), sepsis, and venous thromboembolism. RESULTS: Of 680 enrolled patients, 468 (69%) underwent an emergent procedure. Patients with decreased time to hemostasis were less severely injured, had less deranged base excess on admission, and lower incidence of blunt trauma (all p < 0.05). In 408 (87%) patients in whom hemostasis was achieved, every 15-minute decrease in time to hemostasis was associated with decreased 30-day mortality (RR, 0.97; 95% confidence interval [CI], 0.94–0.99), AKI (RR, 0.97; 95% CI, 0.96–0.98), ARDS (RR, 0.98; 95% CI, 0.97–0.99), MOF (RR, 0.94; 95% CI, 0.91–0.97), and sepsis (RR, 0.98; 95% CI, 0.96–0.99), but not venous thromboembolism (RR, 0.99; 95% CI, 0.96–1.03). CONCLUSION: Earlier time to hemostasis was independently associated with decreased incidence of 30-day mortality, AKI, ARDS, MOF, and sepsis in bleeding trauma patients. Time to hemostasis should be considered as an endpoint in trauma studies and as a potential quality indicator. LEVEL OF EVIDENCE: Therapeutic/care management, level III.